The Global CRO pursues further development in the digitalization of Clinical Research Clinscience US LLC, a subsidiary of Neuca Group, on 26th of April signed an investment agreement to acquire 51% of shares in Agati Systems. The US-based (Texas) Company, together...
Exom is proud to announce to being awarded the GHP Global Excellence Award by Global Health & Pharma as “Most Innovative Full-Service CRO – 2022” for our pioneering and cutting-edge use of technology (with our Genius SUITE™) in clinical trials to...
Having made a name for itself as the ‘Most Innovative Full-Service CRO’ for 2021, the Exom Group has been pushing for the acceptance of digital and technological solutions in Clinical Trials. Whilst there is still a lot of work to be done before the field embraces the...
EXOM, is a globally acting full-service CRO (Contract Research Organization), founded in 2014 in Milan (Italy). Exom’s primary mission is to implement next-generation clinical trial 5.0 processes by exploiting innovative technologies and combining them with our...
International Phase II/III Clinical Trial on Covid-19 Vaccine Milan (Italy), March 19, 2021 – Exom Group srl, the Full Service, Digital & Green CRO is proud to announce the start of subjects’ recruitment for the Phase II part of COVITAR, a multicenter...
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Global Health & Pharma Excellence AwardsAward Winner 2022
Exom is proud to announce that Global Health & Pharma has awarded us the 2022 Global Excellence Award as "Most innovative Full-Service CRO - 2022" for our pioneering, cutting-edge use of technology in clinical trials to support study stakeholders.
